Ascendis Pharma Ownership | Who Owns Ascendis Pharma?

Ascendis Pharma Ownership Summary

Ascendis Pharma is owned by 89.14% institutional investors, 0.82% insiders, and 10.04% retail investors. Ra capital management is the largest institutional shareholder, holding 16.75% of ASND shares. T. Rowe Price Capital Appreciation is the top mutual fund, with 4.46% of its assets in Ascendis Pharma shares.

ASND Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ascendis Pharma	89.14%	0.82%	10.04%
Sector	Healthcare Stocks	35.34%	11.88%	52.77%
Industry	Biotech Stocks	35.37%	11.83%	52.80%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	10.28M	16.75%	$2.35B
Avoro capital advisors	5.06M	8.25%	$1.16B
Westfield capital management co lp	4.81M	7.84%	$1.10B
Lombard odier asset management (europe)	4.27M	7.06%	$5.83M
Fmr	3.88M	6.32%	$886.69M
Artisan partners limited partnership	3.23M	5.26%	$738.84M
Franklin resources	2.05M	3.34%	$469.34M
Capital investors	1.96M	3.19%	$448.05M
Massachusetts financial services co /ma/	1.86M	3.03%	$425.57M
Wellington management group llp	1.76M	2.86%	$402.02M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ra capital management	10.28M	24.92%	$2.35B
Resolute capital asset partners	98.63K	11.87%	$22.56M
Avoro capital advisors	5.06M	11.39%	$1.16B
Tri locum partners lp	174.83K	7.99%	$34.76M
Perceptive advisors	1.53M	6.85%	$350.28M
Ally bridge group (ny)	51.08K	6.18%	$10.16M
Catalio capital management, lp	129.11K	6.17%	$29.53M
Great point partners	75.00K	6.15%	$14.91M
Westfield capital management co lp	4.81M	4.62%	$1.10B
Camber capital management lp	250.00K	4.05%	$43.15M

Top Buyers

Holder	Shares	% Assets	Change
Lombard odier asset management (europe)	4.27M	0.29%	4.27M
Capital world investors	900.52K	0.03%	900.52K
Perceptive advisors	1.53M	6.85%	450.00K
Polar capital	651.71K	0.53%	281.24K
Vestal point capital, lp	375.00K	2.40%	200.00K

Top Sellers

Holder	Shares	% Assets	Change
Janus henderson group	-	-	-4.06M
T. rowe price investment management	-	-	-1.67M
Price t rowe associates inc /md/	-	-	-1.57M
Capital investors	1.96M	0.10%	-1.11M
Sofinnova investments	-	-	-734.28K

New Positions

Holder	Shares	% Assets	Change	Value
Lombard odier asset management (europe)	4.27M	0.29%	4.27M	$5.83M
Capital world investors	900.52K	0.03%	900.52K	$205.98M
Renaissance	117.33K	0.04%	117.33K	$26.84M
Artal group	101.10K	0.35%	101.10K	$13.79M
Perpetual	100.64K	0.35%	100.64K	$23.02M

Sold Out

Holder	Change
Dv trading	-1.00
Rakuten securities	-1.00
Kilter group	-1.00
Peak6	-2.00
Wealthcollab	-3.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	289	-11.62%	54,713,210	-15.41%	89	0.79%	147	-18.78%	101	5.21%
Dec 31, 2025	209	-31.25%	22,626,743	-66.96%	37	0.29%	122	-26.06%	53	-43.62%
Sep 30, 2025	291	15.48%	67,939,274	10.42%	112	1.07%	162	26.56%	88	4.76%
Jun 30, 2025	259	1.57%	63,281,991	-3.50%	105	0.88%	128	-0.78%	87	-2.25%
Mar 31, 2025	32	-85.71%	17,493,613	-72.74%	29	0.23%	16	-87.20%	9	-85.94%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
T. Rowe Price Capital Appreciation	2.74M	4.46%	2.74M
MFS Mid Cap Growth Equity	1.27M	2.06%	-5.90K
MFS Mid Cap Growth A	1.27M	2.06%	-5.90K
Capital Group Growth Fnd of Amer Comp	1.21M	1.97%	-
American Funds Growth Fund of Amer A	1.21M	1.97%	-
Franklin Innovation Composite	1.10M	1.79%	100.00K
Franklin DynaTech A	1.10M	1.79%	100.00K
Vanguard Health Care Inv	1.10M	1.79%	-
Franklin DynaTech Fund A	1.00M	1.63%	-
Janus Henderson Mid Cap Growth MA	976.88K	1.59%	976.88K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 11, 2026	JENSEN FLEMMING STEEN	See Remarks	Sell	$4.64M

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	1
2026 Q1	-	-

ASND Ownership FAQ

Who Owns Ascendis Pharma?

Ascendis Pharma shareholders are primarily institutional investors at 89.14%, followed by 0.82% insiders and 10.04% retail investors. The average institutional ownership in Ascendis Pharma's industry, Biotech Stocks , is 35.37%, which Ascendis Pharma exceeds.

Who owns the most shares of Ascendis Pharma?

Ascendis Pharma’s largest shareholders are Ra capital management (10.28M shares, 16.75%), Avoro capital advisors (5.06M shares, 8.25%), and Westfield capital management co lp (4.81M shares, 7.84%). Together, they hold 32.84% of Ascendis Pharma’s total shares outstanding.

Does Blackrock own Ascendis Pharma?

BlackRock is not among the top 10 institutional shareholders of Ascendis Pharma.

Who is Ascendis Pharma’s biggest shareholder by percentage of total assets invested?

Ra capital management is Ascendis Pharma’s biggest shareholder by percentage of total assets invested, with 24.92% of its assets in 10.28M Ascendis Pharma shares, valued at 2.35B$.

Who is the top mutual fund holder of Ascendis Pharma shares?

T. Rowe Price Capital Appreciation is the top mutual fund holder of Ascendis Pharma shares, with 4.46% of its total shares outstanding invested in 2.74M Ascendis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools